Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Companies Partner on Implanted Diabetes Beta Cell Device

Diabetes blood glucose test

A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device

Trial Shows Gene Therapy Results with Sickle Cell Disease

Sickle cells illustration

Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years. . . . → Read More: Trial Shows Gene Therapy Results with Sickle Cell Disease

State Grant Funds Virus-Immunotherapy Cancer Trial

T-cells and cancer cells

A California state agency is helping fund a clinical trial testing an immunotherapy combined with a cancer-killing virus to treat solid tumor cancers. . . . → Read More: State Grant Funds Virus-Immunotherapy Cancer Trial

Biotech Start-Up Begins Longevity Therapy Work

Older couple

A new biotechnology company has begun developing gene therapies aimed at reprogramming cells damaged by the aging process. . . . → Read More: Biotech Start-Up Begins Longevity Therapy Work

University Lab Licenses Printed Kidney Tissue Process

Kidney organoid with capillary

A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure. . . . → Read More: University Lab Licenses Printed Kidney Tissue Process

Preclinical Test Advances Synthetic Bio ALS Treatment

Motorized wheelchair

A candidate treatment for amyotrophic lateral sclerosis or ALS made with synthetic genetic material is shown to improve motor function and survival in lab mice. . . . → Read More: Preclinical Test Advances Synthetic Bio ALS Treatment

Cell Therapy Start-Up Raises $6M in Seed Funds

Stem cells

A new company providing clinical development and commercialization for emerging cell therapies began operations and raised $6 million in seed funding. . . . → Read More: Cell Therapy Start-Up Raises $6M in Seed Funds

Cell Therapy Biotech Raises $75.5M in Venture Funds

Platelets in Red Cross box

A developer of off-the-shelf genetically engineered platelet cells to treat a range of diseases is raising $75.5 million in its second venture round. . . . → Read More: Cell Therapy Biotech Raises $75.5M in Venture Funds

Stem Cell Patch Shown to Repair Retinal Damage

Red-blue-green eye

Research with lab rats shows a transplanted tissue patch derived from stem cells repairs damaged retinas and helps restore visual functions. . . . → Read More: Stem Cell Patch Shown to Repair Retinal Damage

Off-the-Shelf Stem Cell Company Forms, Gains $72M

Drop of blood

A new enterprise developing packaged blood-forming stem cells as therapies for a range of diseases began operations and raised $72 million in venture funds. . . . → Read More: Off-the-Shelf Stem Cell Company Forms, Gains $72M